ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $391,000 | -37.2% | 48,116 | -10.3% | 0.03% | +41.7% |
| Q2 2019 | $623,000 | -39.9% | 53,614 | -50.7% | 0.02% | -60.0% |
| Q1 2019 | $1,037,000 | +22.6% | 108,800 | +83.2% | 0.06% | +100.0% |
| Q3 2018 | $846,000 | +412.7% | 59,400 | +343.3% | 0.03% | +900.0% |
| Q1 2018 | $165,000 | -90.3% | 13,400 | -88.6% | 0.00% | -88.0% |
| Q4 2017 | $1,706,000 | -17.2% | 117,300 | -19.0% | 0.02% | +4.2% |
| Q3 2017 | $2,060,000 | +262.7% | 144,800 | +236.7% | 0.02% | -11.1% |
| Q1 2016 | $568,000 | -46.6% | 43,000 | -37.9% | 0.03% | -57.8% |
| Q4 2015 | $1,064,000 | +202.3% | 69,200 | +143.7% | 0.06% | +146.2% |
| Q3 2015 | $352,000 | +57.1% | 28,400 | +61.4% | 0.03% | -25.7% |
| Q4 2014 | $224,000 | -62.9% | 17,600 | -47.5% | 0.04% | +20.7% |
| Q1 2014 | $604,000 | +70.6% | 33,500 | +46.3% | 0.03% | -14.7% |
| Q4 2013 | $354,000 | – | 22,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |